| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $17,475,970 ) (Continued on the next page) |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG080636 | ApoE, lipid and immune mechanisms of human neurons and glia | 001 | 2 | NIH | 3/9/2026 | $76,143 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH137400 | Online social networking mechanisms of suicide in adolescents | 000 | 1 | NIH | 2/18/2026 | $193,320 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH132900 | Shared and differential vulnerabilities of stress and reward processing in psychosis-risk syndromes or early-stage depression | 000 | 3 | NIH | 12/3/2025 | $178,416 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA061913 | Written Exposure Therapy embedded into residential substance use treatment: Efficacy and mechanisms for co-occurring substance use and PTSD | 001 | 1 | NIH | 3/20/2026 | $0 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA061913 | Written Exposure Therapy embedded into residential substance use treatment: Efficacy and mechanisms for co-occurring substance use and PTSD | 000 | 1 | NIH | 2/19/2026 | $193,320 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH129828 | Multimodal characterization of affective visual processing in the early aftermath of trauma | 000 | 4 | NIH | 12/1/2025 | $179,707 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD112293 | Elucidating interactions among early life adversity, sleep architecture, and immune function | 000 | 6 | NIH | 1/8/2026 | $103,215 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | UH3DA058544 | Antibody-based therapy for fentanyl-related opioid use disorder | 000 | 2 | NIH | 2/9/2026 | $3,657,445 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32MH125786 | Training to Enhance Alignment of Psychiatry and Neuroscience | 001 | 5 | NIH | 4/17/2026 | $3,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R61DA064788 | Recovery Inspired Support Engagement (RISE) | 001 | 1 | NIH | 4/28/2026 | $0 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R61DA064788 | Recovery Inspired Support Engagement (RISE) | 000 | 1 | NIH | 3/6/2026 | $453,654 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | RF1MH136052 | MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach | 000 | 2 | NIH | 4/24/2026 | $2,876,123 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH138861 | Observing brain lactate dynamics during a working memory task in first episode and chronic schizophrenia | 000 | 2 | NIH | 2/5/2026 | $205,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS127391 | Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands | 000 | 4 | NIH | 5/1/2026 | $432,440 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS129188 | Human iPSC-Based Personalized Cell Therapy of PD | 000 | 4 | NIH | 5/5/2026 | $689,100 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH117292 | Site 3/3, Understanding PTSD through Postmortem Targeted Brain Multiomics | 000 | 7 | NIH | 2/25/2026 | $902,371 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135899 | Leveraging Machine Learning Approaches to Understand Mechanisms of Exposure Therapy in Real-World Settings | 000 | 3 | NIH | 4/1/2026 | $769,765 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH137441 | Tracking the dynamic trajectory of behavioral, physiological, and neurobiological stress responses in female adolescents at high and low familial risk for depression. | 000 | 2 | NIH | 4/27/2026 | $705,959 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135844 | Harnessing smartphones for real-time detection of affective disturbance and future depression risk in adolescents | 000 | 2 | NIH | 12/5/2025 | $669,159 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH137075 | Personalized Quality of Life Measurement | 000 | 3 | NIH | 4/1/2026 | $549,472 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134074 | Imaging the Functional State of the D2high Receptor in drug induced dopamine supersensitivity in schizophrenia | 000 | 3 | NIH | 1/28/2026 | $666,559 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135093 | Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology | 000 | 3 | NIH | 12/12/2025 | $888,999 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 000 | 5 | NIH | 12/10/2025 | $572,264 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 000 | 4 | NIH | 3/23/2026 | $714,786 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA047575 | Neural and Behavioral Consequences of Chronic THC Exposure During Adolescence | 000 | 7 | NIH | 3/30/2026 | $1,235,789 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K24DA061976 | Mentoring in Patient-Oriented Research on Substance Use Disorders | 000 | 2 | NIH | 1/28/2026 | $208,575 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG080636 | ApoE, lipid and immune mechanisms of human neurons and glia | 000 | 2 | NIH | 12/17/2025 | $685,289 |
| | 2026 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH136052 | MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach | 000 | 1 | NIH | 4/20/2026 | $0 |
| | 2026 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32MH125786 | Training to Enhance Alignment of Psychiatry and Neuroscience | 000 | 5 | NIH | 4/16/2026 | $0 |
| | 2026 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R37MH068376 | Neuroimaging Studies of Reward Processing in Depression | 000 | 20 | NIH | 4/6/2026 | $0 |
| | 2026 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH136479 | Utilizing circRNA transcriptomics for functional characterization of psychiatric GWAS | 000 | 2 | NIH | 12/15/2025 | $0 |
| | 2026 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH133114 | Measuring brain lactate and other metabolites in schizophrenia at 3T using an enhanced MR spectroscopy approach | 000 | 2 | NIH | 4/9/2026 | $0 |
| | 2026 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 000 | 5 | NIH | 3/3/2026 | -$36,621 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH119467 | Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making | 000 | 5 | NIH | 2/6/2026 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH122668 | Neural Correlates of Stress and Perceived Control in Adolescent Depression | 000 | 5 | NIH | 4/8/2026 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH119322 | Brain bioenergetics and slow wave activity in first episode psychosis | 000 | 5 | NIH | 11/20/2025 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | U01NS109463 | Parkinsons Disease Scalable iPSC Autologous Cell Therapy | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH131881 | Building normative models of Reinforcement Learning Decision Making Behavior | 000 | 2 | NIH | 12/24/2025 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH120991 | Dysregulation of Appetitive & Aversive Amygdala Circuits in Bipolar Disorder | 000 | 5 | NIH | 4/16/2026 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116969 | Predicting the onset of depression in at-risk adolescents from endophenotype profiles | 000 | 5 | NIH | 2/2/2026 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01HD102974 | Understanding the transgenerational epigenetic effect of maternal psychosocial trauma exposure on infants via lncRNA-sequencing | 000 | 5 | NIH | 2/9/2026 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA054113 | The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder | 000 | 3 | NIH | 3/24/2026 | $0 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA021409 | Human dopamine transporter gene: variation and transcriptional regulation | 000 | 15 | NIH | 1/9/2026 | -$251,291 |
| | 2026 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH119467 | Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making | 001 | 5 | NIH | 4/28/2026 | $0 |
| | 2026 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | UG3DA058544 | Antibody-based therapy for fentanyl-related opioid use disorder | 000 | 1 | NIH | 2/5/2026 | $0 |
| | 2026 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21DA056864 | Role of lateral hypothalamus projections in opioid withdrawal-induced sleep deficits | 000 | 2 | NIH | 12/15/2025 | $0 |
| | 2026 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH117012 | Neuroprogression across the Psychosis Spectrum in the Early Course of Illness | 000 | 5 | NIH | 12/10/2025 | $0 |
| | 2026 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH114982 | Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis | 000 | 5 | NIH | 3/27/2026 | -$1 |
| | 2026 | 2022 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DK120517 | Understanding the Effects of Acute Stressors and Negative Emotion on Eating Behavior in Binge-Eating Disorder: The Role of Stressor-Induced Changes in Reward and Cognitive Control | 000 | 5 | NIH | 3/16/2026 | -$8,081 |
|
